We are live on ! Find out more
SRL

Scientech Research LLC Portfolio holdings

AUM $120M
1-Year Est. Return 73.62%
This Fund
S&P 500
This Quarter Est. Return
+9.74%
1 Year Est. Return
+73.62%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$502M
AUM Growth
+$16.7M
Cap. Flow
-$3.98M
Cap. Flow %
-0.79%
Top 10 Hldgs %
6.62%
Holding
896
New
332
Increased
117
Reduced
140
Closed
306

Top Buys

Rank Stock Value
1
ENSG icon
The Ensign Group
ENSG
+$3.53M
2
SHW icon
Sherwin-Williams
SHW
+$2.6M
3
INTU icon
Intuit
INTU
+$2.55M
4
DLTR icon
Dollar Tree
DLTR
+$2.47M
5
CHTR icon
Charter Communications
CHTR
+$2.39M

Sector Composition

Rank Sector Weight
1 Technology 19.65%
2 Consumer Discretionary 14.3%
3 Healthcare 13.76%
4 Financials 11.63%
5 Industrials 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNW icon
326
Pinnacle West Capital
PNW
$12.8B
$622K 0.12%
7,022
+2,419
+53% +$207K
SLNO
327
DELISTED
Soleno Therapeutics
SLNO
$617K 0.12%
+12,228
New +$585K
EG icon
328
Everest Group
EG
$14.9B
$617K 0.12%
+1,575
New +$600K
GIII icon
329
G-III Apparel Group
GIII
$1.45B
$615K 0.12%
+20,158
New +$552K
VRDN icon
330
Viridian Therapeutics
VRDN
$2.13B
$611K 0.12%
+26,860
New +$439K
BCC icon
331
Boise Cascade
BCC
$2.69B
$601K 0.12%
+4,266
New +$556K
UNH icon
332
UnitedHealth
UNH
$385B
$599K 0.12%
1,024
-1,080
-51% -$611K
ELS icon
333
Equity Lifestyle Properties
ELS
$12.8B
$596K 0.12%
+8,354
New +$586K
GOLD
334
Gold.com Inc
GOLD
$1.15B
$596K 0.12%
+13,488
New +$516K
SM icon
335
SM Energy
SM
$8.03B
$593K 0.12%
14,841
-5,797
-28% -$251K
SAIA icon
336
Saia
SAIA
$11.3B
$593K 0.12%
+1,356
New +$574K
DAR icon
337
Darling Ingredients
DAR
$10.1B
$592K 0.12%
15,933
-4,903
-24% -$185K
IMVT icon
338
Immunovant
IMVT
$8.08B
$590K 0.12%
20,691
+8,057
+64% +$238K
YETI icon
339
Yeti Holdings
YETI
$3.8B
$586K 0.12%
14,277
+315
+2% +$12.4K
ADBE icon
340
Adobe
ADBE
$84.3B
$584K 0.12%
+1,128
New +$619K
CCL icon
341
Carnival Corporation Ltd
CCL
$34.6B
$583K 0.12%
+31,569
New +$535K
GH icon
342
Guardant Health
GH
$19.9B
$583K 0.12%
25,419
-33,604
-57% -$951K
RXRX icon
343
Recursion Pharmaceuticals
RXRX
$1.6B
$581K 0.12%
88,103
-52,192
-37% -$374K
EA icon
344
Electronic Arts
EA
$52.4B
$577K 0.11%
4,024
-11,220
-74% -$1.63M
LBTYA icon
345
Liberty Global Class A
LBTYA
$3.48B
$577K 0.11%
27,340
-52,411
-66% -$1.01M
FN icon
346
Fabrinet
FN
$18.6B
$575K 0.11%
+2,434
New +$563K
OIH icon
347
VanEck Oil Services ETF
OIH
$2.01B
$573K 0.11%
+2,018
New +$609K
HIMS icon
348
Hims & Hers Health
HIMS
$7.58B
$568K 0.11%
30,820
-42,185
-58% -$755K
RPM icon
349
RPM International
RPM
$13.4B
$567K 0.11%
+4,686
New +$542K
NMIH icon
350
NMI Holdings
NMIH
$3.16B
$566K 0.11%
+13,743
New +$530K

Similar funds

Scientech Research LLC's Q3 2024 Portfolio in Review

As of Q3 2024, Scientech Research LLC held 896 positions worth $502M, up 3.4% from $485M the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

Scientech Research LLC's Q3 2024 filing shows 332 new, 117 increased, 140 reduced and 306 closed positions. Its largest new stake was The Ensign Group: 24,750 shares worth $3.56M. The largest sale was Agilent Technologies, an estimated $4.09M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Scientech Research LLC's largest Q3 2024 buy was The Ensign Group: 24,750 shares worth $3.56M.
  • Scientech Research LLC added most to Ulta Beauty in Q3 2024, an estimated $2.38M increase.
  • Scientech Research LLC's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $2.61M.
  • Scientech Research LLC fully exited Agilent Technologies in Q3 2024, selling an estimated $4.09M.
  • Scientech Research LLC's ten largest holdings make up 6.6% of its $502M portfolio in Q3 2024.
  • Scientech Research LLC opened 332 new positions and closed 306 in Q3 2024.
  • Scientech Research LLC's portfolio value rose 3.4% quarter-over-quarter to $502M.

Based on Scientech Research LLC's 13F filing for Q3 2024, filed 14 Nov 2024.